National and Kapodistrian University of Athens
Ταυτοποίηση προγνωστικών δεικτών επιθετικής βιολογικής συμπεριφοράς στον καρκίνο του κόλου
Abstract
dc:descriptionPURPOSE AND METHODS Modern perception of carcinogenesis and tumor biology enlists genes-proteins that canact as oncogenes or tumor suppressive factors. Tumor initiation requires –according to theaforementioned- the constant activation of oncogenes together with silencing of the tumorsuppressors.We utilized validated methods of immunohistochemistry in 183 samples of surgicallyremoved adenocarcinomas of the colon and rectum to assess for protein expression patterns ofEGFR, c-Met, CD44v6, FAK, VEGFR-1, VEGFR-3 and caveolin-1. We statistically processedthe results with every available clinical, epidemiological and pathological parameter.RESULTSEGFR, c-Met, Cd44v6, FAK and VEGFR-3 were positively expressed in 50%, 71.6%,41.6%, 20% και 42.6% of patient tissues respectively, while caveolin-1 and VEGFR-1 hadexpression rates of 40.4% and 42.6% respectively. The correlations of the burdening factorswith stage were in every case statistically valid, while the Kaplan-Meier estimates proved them each to be significant negative prognostic agent.Lack of VEGFR-1 predicted hematogenous metastasis and was a positive prognosticfactor (p=0.071). Caveolin-1 did not achieve statistical significance in its bivariate correlations,and it appeared to be a not statistically significant positive prognostic factor in the wholesample. However it reached statistical value as a prognostic factor when we recoded for earlytumor stages (AJCC stages I and II) and as to the advanced cancer group (III, IV) its absenceimplied worse stage.Cox proportional hazards regression analysis concluded that FAK, CD44v6 andcaveolin-1 were independent prognostic factors. CONCLUSIONThe results of the current doctoral dissertation confirm –in the specific patient sampletherole of tumor promoting factors EGFR, c-Met, CD44v6 and FAK and provided useful datato the community regarding the less well studied VEGR-1, VEGFR-3 and caveolin-1. Throughthe evaluation of our sample emerged a tumor protective quality of VEGFR-1 and Caveolin-1for colorectal cancer patients. VEGFR-3 was related to lymphatic dissemination of tumor cellsand advanced cancer stage. In the clinical setting, the ramifications of our results extend toboth diagnosis –mainly based on staging- and treatment. Future validation of our research canlead to the use of cellular receptors as surrogate tumor markers identifying aggressivebiological behavior. Bridging the gap from genotype to phenotype will signify moreappropriate patient treatment options, based on the deeper knowledge of tumor biology andindividual targeting of patients’ distinct characteristics.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Garouniatis, Alexandros
- Γαρουνιάτης, Αλέξανδρος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40260